DOP2002000474A - Nuevas formas cristalinas anhidras de la gabapentina - Google Patents
Nuevas formas cristalinas anhidras de la gabapentinaInfo
- Publication number
- DOP2002000474A DOP2002000474A DO2002000474A DO2002000474A DOP2002000474A DO P2002000474 A DOP2002000474 A DO P2002000474A DO 2002000474 A DO2002000474 A DO 2002000474A DO 2002000474 A DO2002000474 A DO 2002000474A DO P2002000474 A DOP2002000474 A DO P2002000474A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- new
- gabapentina
- anhydra
- crystal shapes
- new crystalline
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 3
- WRSFRDZQQUAKNA-UHFFFAOYSA-N 2-[1-(aminomethyl)cyclohexyl]acetic acid;hydrate Chemical compound O.OC(=O)CC1(CN)CCCCC1 WRSFRDZQQUAKNA-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen nuevas anhidras cristalinas de gabapentina formadas a partir de gabapentina monohidrato. Las nuevas formas cristalinas ofrecen ventajas para la elaboración del agente terapéutico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837501P | 2001-10-09 | 2001-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000474A true DOP2002000474A (es) | 2003-04-15 |
Family
ID=34589923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000474A DOP2002000474A (es) | 2001-10-09 | 2002-10-01 | Nuevas formas cristalinas anhidras de la gabapentina |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR036695A1 (es) |
| DO (1) | DOP2002000474A (es) |
| GT (1) | GT200200204A (es) |
| HN (1) | HN2002000283A (es) |
| MY (1) | MY129370A (es) |
| PA (1) | PA8555901A1 (es) |
| PE (1) | PE20030689A1 (es) |
| PY (1) | PY0224072A (es) |
| SV (1) | SV2004001275A (es) |
| TW (1) | TWI245033B (es) |
| UA (1) | UA77021C2 (es) |
| UY (1) | UY27473A1 (es) |
| ZA (1) | ZA200402519B (es) |
-
2002
- 2002-03-10 UA UA20040503407A patent/UA77021C2/uk unknown
- 2002-09-25 TW TW91122057A patent/TWI245033B/zh not_active IP Right Cessation
- 2002-09-27 AR ARP020103664 patent/AR036695A1/es unknown
- 2002-10-01 DO DO2002000474A patent/DOP2002000474A/es unknown
- 2002-10-01 PY PY200200224072A patent/PY0224072A/es unknown
- 2002-10-04 HN HN2002000283A patent/HN2002000283A/es unknown
- 2002-10-04 MY MYPI20023726 patent/MY129370A/en unknown
- 2002-10-04 PE PE2002000988A patent/PE20030689A1/es not_active Application Discontinuation
- 2002-10-07 UY UY27473A patent/UY27473A1/es not_active Application Discontinuation
- 2002-10-08 SV SV2002001275A patent/SV2004001275A/es not_active Application Discontinuation
- 2002-10-09 PA PA8555901A patent/PA8555901A1/es unknown
- 2002-10-09 GT GT200200204A patent/GT200200204A/es unknown
-
2004
- 2004-03-30 ZA ZA200402519A patent/ZA200402519B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200200204A (es) | 2003-05-23 |
| AR036695A1 (es) | 2004-09-29 |
| PA8555901A1 (es) | 2003-06-30 |
| MY129370A (en) | 2007-03-30 |
| SV2004001275A (es) | 2004-02-24 |
| HN2002000283A (es) | 2005-02-22 |
| UA77021C2 (en) | 2006-10-16 |
| PE20030689A1 (es) | 2003-08-11 |
| UY27473A1 (es) | 2003-05-30 |
| ZA200402519B (en) | 2005-01-24 |
| TWI245033B (en) | 2005-12-11 |
| PY0224072A (es) | 2004-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1485127E (pt) | Administração de agentes para o tratamento de inflamação | |
| EA200400481A1 (ru) | Применение флибансерина для лечения половых расстройств | |
| CY2016031I1 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| EA200501222A1 (ru) | Дигидроптеридиноны, способ их получения и их применение в качестве лекарственных средств | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| IS7215A (is) | Aðferðir til að meðhöndla nýæðarsjúkdóma í augum | |
| CY1110019T1 (el) | Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| ATE344226T1 (de) | Aspirin-ausgelöste lipidmediatoren | |
| DE60239558D1 (de) | Kombinationen für die behandlung von immun-entzündlichen erkrankungen | |
| NO20034176D0 (no) | Pyrazolopyrimidiner som terapeutiske midler | |
| PT1411926E (pt) | Inibidores de integrina para o tratamento de doencas oftalmicas | |
| IS7909A (is) | Aðferð til að framleiða ljósfræðilega hrein virk efnasambönd | |
| EA200400417A1 (ru) | Новые безводные кристаллические формы габапентина | |
| UY27473A1 (es) | Nuevas formas cristalinas anhidras de la gabapentina | |
| ITGE20020050A0 (it) | Procedimento per il trattamento di filati mediante agugliatura. | |
| ECSP045042A (es) | Nuevas formas cristalinas anhidras de la gabapentina | |
| CR7318A (es) | Nuevas formas cristalinas anhidras de la gabapentina | |
| IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. | |
| ITTO20020997A1 (it) | Procedimento autoalllineato per la fabbricazione di | |
| ITMI20041822A1 (it) | "agente terapeutico utile per il trattamento di neoplasie plasmacellulari" | |
| DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
| IS8477A (is) | Beta-laktöm til að meðhöndla MTK sjúkdóma | |
| BR9812265A (pt) | Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias. | |
| ITRM20010770A1 (it) | Procedimento per la produzione di piridinolcarbammato. |